Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.12% |
| 2 | Technology | 12.96% |
| 3 | Healthcare | 12.08% |
| 4 | Industrials | 11.23% |
| 5 | Consumer Staples | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Titan Machinery
TITN
$420M
| $1.19M | ﹤0.01% |
+81,500
| New | +$972K |
|
|
AAV
2477
DELISTED
Advantage Oil & Gas Ltd
AAV
| $1.19M | ﹤0.01% |
175,800
-36,500
| -17% | -$256K |
|
|
MDLY
2478
DELISTED
Medley Management Inc
MDLY
| $1.19M | ﹤0.01% |
11,975
+5,545
| +86% | +$511K |
|
|
PER
2479
DELISTED
SANDRIDGE PERMIAN TRUST
PER
| $1.19M | ﹤0.01% |
401,992
+323,882
| +415% | +$984K |
|
2480
Fair Isaac
FICO
$31.8B
| $1.18M | ﹤0.01% |
+9,922
| New | +$1.18M |
|
|
DRNA
2481
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.18M | ﹤0.01% |
408,682
+84,682
| +26% | +$301K |
|
|
SXCP
2482
DELISTED
SunCoke Energy Partners, L.P.
SXCP
| $1.18M | ﹤0.01% |
61,086
-6,514
| -10% | -$121K |
|
|
CTLP
2483
DELISTED
Cantaloupe
CTLP
| $1.17M | ﹤0.01% |
270,900
-5,000
| -2% | -$22.7K |
|
2484
Ethan Allen Interiors
ETD
$600M
| $1.16M | ﹤0.01% |
31,600
-3,700
| -10% | -$124K |
|
2485
RF Industries
RFIL
$116M
| $1.16M | ﹤0.01% |
665,000
-7,600
| -1% | -$13.1K |
|
|
KTEC
2486
DELISTED
Key Technology Inc
KTEC
| $1.16M | ﹤0.01% |
100,400
-10,400
| -9% | -$115K |
|
|
HGG
2487
DELISTED
hhgregg Inc.
HGG
| $1.16M | ﹤0.01% |
811,800
+13,700
| +2% | +$22K |
|
2488
Gildan
GIL
$9.49B
| $1.16M | ﹤0.01% |
45,600
-117,900
| -72% | -$3.14M |
|
|
FNBC
2489
DELISTED
First NBC Bank Holding Company
FNBC
| $1.15M | ﹤0.01% |
158,000
-63,200
| -29% | -$500K |
|
2490
Hennessy Advisors
HNNA
$77.4M
| $1.15M | ﹤0.01% |
54,150
+10,050
| +23% | +$213K |
|
2491
Verastem
VSTM
$528M
| $1.15M | ﹤0.01% |
85,183
+10,216
| +14% | +$152K |
|
|
PNTR
2492
DELISTED
Pointer Telocation Ltd.
PNTR
| $1.14M | ﹤0.01% |
168,300
+20,400
| +14% | +$152K |
|
2493
Flanigan's Enterprises
BDL
$70.6M
| $1.13M | ﹤0.01% |
46,500
+300
| +0.6% | +$7K |
|
|
BLCM
2494
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $1.13M | ﹤0.01% |
+8,290
| New | +$1.47M |
|
2495
Great Elm Group
GEG
$68.7M
| $1.13M | ﹤0.01% |
300,654
+24,979
| +9% | +$106K |
|
|
JCTC
2496
Jewett-Cameron Trading
JCTC
$8.98M
| $1.12M | ﹤0.01% |
174,200
+6,400
| +4% | +$38.5K |
|
2497
AtriCure
ATRC
$2.08B
| $1.12M | ﹤0.01% |
57,200
-31,700
| -36% | -$575K |
|
|
MNTX
2498
DELISTED
Manitex International, Inc.
MNTX
| $1.12M | ﹤0.01% |
+163,100
| New | +$916K |
|
2499
Oceaneering
OII
$4.64B
| $1.12M | ﹤0.01% |
39,600
-375,200
| -90% | -$10.1M |
|
2500
OneMain Financial
OMF
$7.27B
| $1.11M | ﹤0.01% |
+50,300
| New | +$1.24M |
|
Similar funds
Renaissance Technologies's Q4 2016 Portfolio in Review
As of Q4 2016, Renaissance Technologies held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Renaissance Technologies deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Renaissance Technologies's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Renaissance Technologies added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Renaissance Technologies's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Renaissance Technologies fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Renaissance Technologies's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Renaissance Technologies opened 418 new positions and closed 494 in Q4 2016.
- Renaissance Technologies's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.